联合治疗与单一治疗在恶性黑色素瘤中的有效性和成本效益
Dilay Özdemir1, Melanie Büssgen2
1University of Hamburg, Hamburg, Germany.
Journal of pharmaceutical policy and practice
|September 25, 2023
概括
组合治疗改善了恶性黑色素瘤 (MM) 患者的生存率. 免疫检查点抑制剂 (ICI) 组合是具有成本效益的,但BRAF/MEK抑制剂组合不是.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
背景情况:
- 先进的恶性黑色素瘤 (MM) 历史上在2010年之前的预后很差.
- 免疫检查点抑制剂 (ICI) 从2011年开始彻底改变了MM治疗.
- 组合疗法成为高级MM的有希望的策略,第一个是在2016年批准的.
研究的目的:
- 评估组合治疗与单一治疗对III或IV期MM的成本效益.
- 为了比较组合疗法与单一疗法的有效性 (存活率,反应率).
主要方法:
- 在主要数据库 (Web of Science,PubMed等) 进行系统的文献搜索. ) 的情况.
- 包括过去十年的随机对照试验 (RCT) 和成本效益分析.
- 关注质量调整后生命年 (QALY) 的成本和临床有效性指标.
主要成果:
- 十一项RCT和五项成本效益分析符合纳入标准.
- 九项临床试验显示,组合治疗优于单一治疗.
- BRAF/MEK 抑制剂组合治疗没有成本效益;ICI组合是成本效益的.
结论:
- 结合疗法提供优越的疗效,与单一治疗相比,在先进的MM.
- 联合免疫检查点抑制剂 (ICI) 证明了成本效益.
- 用BRAF和MEK抑制剂进行联合治疗不是一个具有成本效益的策略.
关键词:
这是一种BRAF抑制剂.组合疗法是一种联合疗法.经济效益性 经济效益性有效性 有效性.免疫检查点抑制剂 免疫检查点抑制剂这是一种MEK抑制剂.恶性黑色素瘤是一种恶性黑色素瘤.黑色素瘤是一种黑色素瘤.在瘤学瘤学.有针对性的治疗.更多相关视频
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.4K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.0K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
